🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
BAX
$BAX
🔒 US EquitiesBaxter International Inc.
AVG HISTORICAL GAP
-0.94%
MAX GAP RECORD
+17.36%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $BAX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$BAX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (BEFORE OPEN (08:00)) |
+2.12%
|
| Jul 30, 2026 Earnings Release 2026-07-30 (BEFORE OPEN) |
+17.36%
|
| Apr 30, 2026 Earnings Release 2026-04-30 (AFTER CLOSE) |
+1.48%
|
| Feb 12, 2026 Earnings Release 2026-02-12 (BEFORE OPEN) |
-12.35%
|
| Oct 30, 2025 Earnings Release 2025-10-30 (BEFORE OPEN) |
-15.52%
|
| Jul 30, 2025 Earnings Release 2025-07-30 (AFTER CLOSE) |
-15.29%
|
| May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN) |
-0.39%
|
| Feb 05, 2025 Earnings Release 2025-02-05 (BEFORE OPEN) |
+0.83%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.5%
Bullish Gaps (5)
Bearish Gaps (3)
Neutral / Flat (8)
📖 Intelligence Summary
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals;…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗